Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 2, 2009, Pages 469-477

  Maran, Rengasamy R M ^a   Thomas, Ann ^a   Roth, Megan ^a   Sheng, Zhonghua ^a   Esterly, Noriko ^a   Pinson, David ^a   Gao, Xin ^b   Zhang, Yawei ^c   Ganapathy, Vadivel ^d   Gonzalez, Frank J ^e   Guo, Grace L ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CYCLIN D1; FARNESOID X RECEPTOR; INTERLEUKIN 6;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLON POLYPOSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INTESTINE CARCINOMA; INTESTINE EPITHELIUM; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AZOXYMETHANE; CARCINOGENICITY TESTS; CELL PROLIFERATION; COLON; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; INTESTINAL NEOPLASMS; INTESTINES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 59649084903     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.145409     Document Type: Article

References (37)

1. Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, Auwerx J, et al. (2004) Synergy between LRH-1 and [beta]-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell 15:499-509.
2. Campbell RL, Singh DV, and Nigro ND (1975) Importance of the fecal stream on the induction of colon tumors by azoxymethane in rats. Cancer Res 35:1369-1371.
3. Corpet DE and Pierre F (2003) Point: From animal models to prevention of colon cancer: systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 12:391-400.
4. Dawson MI, Xia Z, Liu G, Ye M, Fontana JA, Farhana L, Patel BB, Arumugarajah S, Bhuiyan M, Zhang XK, et al. (2007) An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity. J Med Chem 50:2622-2639.
5. De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, Rubbia-Brandt L, Frossard JL, Dinjens WN, Rabinovitch PS, et al. (2006) Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer 5:48.
6. De Gottardi A, Touri F, Maurer CA, Perez A, Maurhofer O, Ventre G, Bentzen CL, Niesor EJ, and Dufour JF (2004) The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig Dis Sci 49:982-989.
7. Farhana L, Dawson MI, Leid M, Wang L, Moore DD, Liu G, Xia Z, and Fontana JA (2007) Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor. Cancer Res 67:318-325.
8. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, et al. (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693.
9. Gumbiner BM (1997) Carcinogenesis: a balance between beta-catenin and APC. Curr Biol 7:R443-R446.
10. Guo GL, Santamarina-Fojo S, Akiyama TE, Amar MJ, Paigen BJ, Brewer B Jr, and Gonzalez FJ (2006) Effects of FXR in foam-cell formation and atherosclerosis development. Biochim Biophys Acta 1761:1401-1409.
11. He N, Park K, Zhang Y, Huang J, Lu S, and Wang L (2008) Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 134:793-802.
12. Hill MJ (1974) Colon cancer: a disease of fibre depletion or of dietary excess? Digestion 11:289-306.
13. Hwang ST, Urizar NL, Moore DD, and Henning SJ (2002) Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor. Gastroenterology 122:1483-1492.
14. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, et al. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217-225.
15. Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M, Yu RT, Shelton JM, Richardson JA, Repa JJ, et al. (2006) Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 103:3920-3925.
16. Jaiswal AS and Narayan S (2004) Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cells. J Cell Biochem 93:345-357.
17. Journe F, Laurent G, Chaboteaux C, Nonclercq D, Durbecq V, Larsimont D, and Body JJ (2008) Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation. Breast Cancer Res Treat 107:49-61.
18. Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, and Gonzalez FJ (2007a) Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48:2664-2672.
19. Kim I, Morimura K, Shah Y, Yang Q, Ward JM, and Gonzalez FJ (2007b) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28:940-946.
20. Lambert G, Amar MJ, Guo G, Brewer HB Jr, Gonzalez FJ, and Sinal CJ (2003) The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 278:2563-2570.
21. Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ, and Edwards PA (2006) FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J Lipid Res 47:201-214.
22. Mahmoud NN, Dannenberg AJ, Bilinski RT, Mestre JR, Chadburn A, Churchill M, Martucci C, and Bertagnolli MM (1999) Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis 20:299-303.
23. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, and Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362-1365.
24. Moser AR, Pitot HC, and Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324.
25. Nambiar PR, Girnun G, Lillo NA, Guda K, Whiteley HE, and Rosenberg DW (2003) Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol 22:145-150.
26. Nigro ND (1985) Animal model for colorectal cancer. Prog Clin Biol Res 186:161-173.
27. Nigro ND, Singh DV, Campbell RL, and Sook M (1975) Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats. J Natl Cancer Inst 54:439-442.
28. Pai R, Tarnawski AS, and Tran T (2004) Deoxycholic acid activates {beta}-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell 15:2156-2163.
29. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, et al. (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368.
30. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, and Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-744.
31. Stamp DH (2002) Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy. Med Hypotheses 59:398-405.
32. Swales KE, Korbonits M, Carpenter R, Walsh DT, Warner TD, and Bishop-Bailey D (2006) The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Cancer Res 66:10120-10126.
33. Umar S, Wang Y, and Sellin JH (2005) Epithelial proliferation induces novel changes in APC expression. Oncogene 24:6709-6718.
34. Wang H, Chen J, Hollister K, Sowers LC, and Forman BM (1999) Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3:543-553.
35. Whiteley LO, Hudson L Jr, and Pretlow TP (1996) Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol Pathol 24:681-689.
36. Yang F, Huang X, Yi T, Yen Y, Moore DD, and Huang W (2007) Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res 67:863-867.
37. Zhang Y, Xu P, Park K, Choi Y, Moore DD, and Wang L (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48:289-298.